Canopy Growth Corporation (CGC)
NASDAQ: CGC · Real-Time Price · USD
1.020
+0.110 (12.09%)
At close: Apr 1, 2025, 4:00 PM
0.9958
-0.0240 (-2.37%)
Pre-market: Apr 2, 2025, 6:21 AM EDT
Canopy Growth Market Cap
Canopy Growth has a market cap or net worth of $161.36 million as of April 2, 2025. Its market cap has decreased by -36.07% in one year.
Market Cap
161.36M
Enterprise Value
375.23M
1-Year Change
-36.07%
Ranking
Category
Stock Price
$1.02
Market Cap Chart
Since May 24, 2018, Canopy Growth's market cap has decreased from $5.67B to $161.36M, a decrease of -97.15%. That is a compound annual growth rate of -40.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 133.90M | -53.62% |
| Dec 31, 2024 | 288.70M | -31.86% |
| Dec 29, 2023 | 423.70M | -62.25% |
| Dec 30, 2022 | 1.12B | -67.34% |
| Dec 31, 2021 | 3.44B | -62.54% |
| Dec 31, 2020 | 9.17B | 26.27% |
| Dec 31, 2019 | 7.26B | 34.51% |
| Dec 31, 2018 | 5.40B | -4.72% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |